Getein Biotech, Inc (SHA:603387)
China · Delayed Price · Currency is CNY 9.27
-0.03 (-0.32%)
Sep 4, 2026, 3:00 PM CST
Getein Biotech Market Cap
Getein Biotech has a market cap or net worth of 4.69 billion as of September 4, 2026. Its market cap has increased by 10.51% in one year.
Market Cap
4.69B
Enterprise Value
3.46B
Revenue
1.09B
Ranking
n/a
PE Ratio
15.57
Stock Price
9.27
ChartMarket Cap Chart
Since July 17, 2017, Getein Biotech's market cap has increased from 4.23B to 4.69B, an increase of 10.92%. That is a compound annual growth rate of 1.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.70B | 10.75% |
| Dec 31, 2025 | 4.24B | 1.45% |
| Dec 31, 2024 | 4.18B | -25.00% |
| Dec 29, 2023 | 5.58B | -12.00% |
| Dec 30, 2022 | 6.34B | -12.61% |
| Dec 31, 2021 | 7.25B | -18.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding